B.C. Millar - Concepedia

Author

B.C. Millar

Also Known As

B C Millar, B C. Millar, B Cherie Millar, B. C. Millar, B. CHERIE MILLAR, B. Cherie Millar, B.C. Millar, B.Cherie Millar, Beverly C Millar, Beverly C. Millar

Publications

468

Citations

H-Index

Concepts

All Affiliations

Belfast City Hospital University of Ulster Royal Victoria Hospital Queen's University Belfast Azabu University

About

B.C. Millar is an author at Belfast City Hospital specializing in medicine, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	153
2	Health Sciences	2	2	32
3	Public Health	2	2	32
4	Biochemistry	1	1	31
5	Biology	1	1	21

B.C. Millar

Publications

209

Citations

H-Index

Page 1

	Year	Citations
Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF) Yasunori Maeda, Colin E. Goldsmith, Wilson A. Coulter, Journal of Antimicrobial Chemotherapy	2009	33
Characterization of Urease-Positive Thermophilic <i>Campylobacter</i> Subspecies by Multilocus Enzyme Electrophoresis Typing Motoo Matsuda, Aki Kaneko, Timothy Stanley, Applied and Environmental Microbiology BiochemistryMedicineBacteriologyCampylobacter Lari IsolatesC. Lari Isolates	2003	31
Development of a genus-specific PCR assay for the molecular detection, confirmation and identification of <i>Fusobacterium</i> spp Yuriko Nagano, M. Watabe, K. G. Porter, British Journal of Biomedical Science Medical MicrobiologyPathogen DetectionMedicineBacteriologyGenus-specific Pcr Assay	2007	21
Population structure and characterization of viridans group streptococci (VGS) isolated from the upper respiratory tract of patients in the community. Takuya Nakajima, Shigeyuki Nakanishi, Charlene Mason, PubMed Upper Respiratory TractKlebsiella PneumoniaeAntibiotic ResistanceAntibiotic SusceptibilityMedical Microbiology	2013	21
Microbial ecology of the cystic fibrosis lung: does microflora type influence microbial loading? John E. Moore, A. Shaw, B.C. Millar, British Journal of Biomedical Science Api 20NeMedicineRespiratory InfectionInfectious Respiratory DiseasePulmonary Fibrosis	2005	19
In vitro antimicrobial activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and other non-fermenting Gram-negative bacteria in adults with cystic fibrosis Andrea Gramegna, B.C. Millar, Francesco Blasi, Journal of Global Antimicrobial Resistance Antimicrobial SusceptibilityAntibioticsPseudomonas AeruginosaAntimicrobial TherapyMicrobiology	2018	18
Occurrence of Campylobacter spp. in water in Northern Ireland: implications for public health. John E. Moore, Patricia Caldwell, B.C. Millar, PubMed Drinking WaterMicrobial ContaminationEnvironmental HealthNorthern IrelandWaterborne Diseases	2001	17
Emergence of Scedosporium apiospermum in patients with cystic fibrosis Yuriko Nagano, B.C. Millar, Colin E. Goldsmith, Archives of Disease in Childhood Family MedicineQuality Of LifeFamily MembersPathologyHealth Psychology	2007	15
Antibacterial effects on Acinetobacter species of commonly employed antineoplastic agents used in the treatment of haematological malignancies: an <i>in vitro</i> laboratory evaluation Alexandra McCarron, Christina M. Armstrong, G. Glynn, British Journal of Biomedical Science	2012	13
193 In vitro synergistic effect of NaCl and antibiotics against P. aeruginosa from cystic fibrosis patients Andrea Gramegna, B.C. Millar, Martina Contarini, Journal of Cystic Fibrosis Antimicrobial SusceptibilityHealth SciencesAntibioticsVitro Synergistic EffectMedicine	2017	11

Page 1